Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-03-02 Sale | 2026-03-02 7:05 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 8,148 | $15.44 | $125,793 | 34,601 (Direct) | View |
| 2026-02-09 Sale | 2026-02-09 7:47 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 14,261 | $16.66 | $237,618 | 42,749 (Direct) | View |
| 2026-01-30 Sale | 2026-01-30 8:39 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 3,661 | $16.6 | $60,767 | 91,902 (Direct) | View |
| 2026-01-30 Sale | 2026-01-30 8:38 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 4,421 | $16.6 | $73,381 | 103,485 (Direct) | View |
| 2026-01-30 Sale | 2026-01-30 8:36 pm | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 4,895 | $16.6 | $81,249 | 130,147 (Direct) | View |
| 2026-01-20 Sale | 2026-01-20 7:57 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,760 | $18.42 | $69,273 | 59,540 (Direct) | View |
| 2025-12-18 Sale | 2025-12-18 6:08 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,760 | $17.9 | $67,314 | 63,300 (Direct) | View |
| 2025-11-24 Sale | 2025-11-24 6:06 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 37,600 | $17.07 | $641,697 | 67,060 (Direct) | View |
| 2025-11-03 Sale | 2025-11-03 7:14 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 6,284 | $12.56 | $78,931 | 37,592 (Direct) | View |
| 2025-10-30 Sale | 2025-10-30 6:06 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 3,130 | $12.8 | $40,054 | 101,847 (Direct) | View |
| 2025-10-30 Sale | 2025-10-30 6:02 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,644 | $12.8 | $46,631 | 107,906 (Direct) | View |
| 2025-10-30 Sale | 2025-10-30 6:01 pm | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 4,087 | $12.8 | $52,300 | 135,042 (Direct) | View |
| 2025-08-01 Sale | 2025-08-01 5:09 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 5,402 | $11.03 | $59,598 | 35,512 (Direct) | View |
| 2025-07-30 Sale | 2025-07-30 6:49 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 4,304 | $12.01 | $51,695 | 110,379 (Direct) | View |
| 2025-07-30 Sale | 2025-07-30 6:49 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,841 | $12.01 | $46,134 | 111,550 (Direct) | View |
| 2025-07-30 Sale | 2025-07-30 6:48 pm | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 4,308 | $12.01 | $51,743 | 139,129 (Direct) | View |
| 2025-05-02 Sale | 2025-05-02 6:18 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 6,198 | $11.33 | $70,243 | 33,724 (Direct) | View |
| 2025-04-30 Sale | 2025-04-30 7:35 pm | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 3,377 | $11.5 | $38,841 | 109,137 (Direct) | View |
| 2025-04-30 Sale | 2025-04-30 7:35 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 2,894 | $11.5 | $33,286 | 81,091 (Direct) | View |
| 2025-04-30 Sale | 2025-04-30 7:35 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 2,438 | $11.5 | $28,041 | 86,581 (Direct) | View |
| 2025-03-03 Sale | 2025-03-03 5:29 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 5,825 | $14.49 | $84,388 | 33,724 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-10 Option Award | 2026-02-10 6:09 pm | N/A 2036-02-09 | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 136,625 | $0 | 136,625 (Direct) | View |
| 2026-02-10 Option Award | 2026-02-10 5:55 pm | N/A 2036-02-09 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 136,625 | $0 | 136,625 (Direct) | View |
| 2026-02-10 Option Award | 2026-02-10 5:50 pm | N/A 2036-02-09 | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 136,625 | $0 | 136,625 (Direct) | View |
| 2026-02-10 Option Award | 2026-02-10 5:43 pm | N/A 2036-02-09 | Nurix Therapeutics Inc. | NRIX | SANDS ARTHUR T President, CEO | 562,500 | $0 | 562,500 (Direct) | View |
| 2026-02-03 Exercise | 2026-02-03 9:12 pm | N/A 2026-02-10 | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 31,333 | $0 | 115,005 (Direct) | View |
| 2026-02-03 Exercise | 2026-02-03 9:12 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 31,333 | $0.84 | 115,005 (Direct) | View |
| 2026-01-30 Exercise | 2026-01-30 8:39 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 11,496 | $0 | 91,902 (Direct) | View |
| 2026-01-30 Exercise | 2026-01-30 8:38 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 10,534 | $0 | 103,485 (Direct) | View |
| 2026-01-30 Exercise | 2026-01-30 8:36 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 11,816 | $0 | 130,147 (Direct) | View |
| 2026-01-20 Exercise | 2026-01-20 7:57 pm | N/A 2029-09-30 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,760 | $0 | 59,540 (Direct) | View |
| 2026-01-20 Exercise | 2026-01-20 7:57 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,760 | $1.86 | 59,540 (Direct) | View |
| 2025-12-18 Exercise | 2025-12-18 6:08 pm | N/A 2029-09-30 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,760 | $0 | 63,300 (Direct) | View |
| 2025-12-18 Exercise | 2025-12-18 6:08 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,760 | $1.86 | 63,300 (Direct) | View |
| 2025-11-24 Exercise | 2025-11-24 6:06 pm | N/A 2029-09-30 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 37,600 | $0 | 67,060 (Direct) | View |
| 2025-11-24 Exercise | 2025-11-24 6:06 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 37,600 | $1.86 | 67,060 (Direct) | View |
| 2025-11-06 Option Award | 2025-11-10 07:19 am | N/A 2035-11-06 | Nurix Therapeutics Inc. | NRIX | DANSEY ROGER D Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2025-10-30 Exercise | 2025-10-30 6:06 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 11,494 | $0 | 101,847 (Direct) | View |
| 2025-10-30 Exercise | 2025-10-30 6:02 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 10,532 | $0 | 107,906 (Direct) | View |
| 2025-10-30 Exercise | 2025-10-30 6:01 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 11,815 | $0 | 135,042 (Direct) | View |
| 2025-10-14 Option Award | 2025-10-23 7:04 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 20,000 | $0 | 20,000 (Direct) | View |
| 2025-09-17 Exercise | 2025-09-17 6:58 pm | N/A 2029-12-22 | Nurix Therapeutics Inc. | NRIX | GREGORY JULIA P Director | 10,750 | $0 | 33,333 (Direct) | View |
| 2025-09-17 Exercise | 2025-09-17 6:58 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | GREGORY JULIA P Director | 10,750 | $1.86 | 33,333 (Direct) | View |
| 2025-07-30 Exercise | 2025-07-30 6:49 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 11,494 | $0 | 110,379 (Direct) | View |
| 2025-07-30 Exercise | 2025-07-30 6:49 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 10,532 | $0 | 111,550 (Direct) | View |
| 2025-07-30 Exercise | 2025-07-30 6:48 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 11,815 | $0 | 139,129 (Direct) | View |
| 2025-05-19 Option Award | 2025-05-19 5:33 pm | N/A 2035-05-18 | Nurix Therapeutics Inc. | NRIX | Silva Paul M Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2025-05-19 Option Award | 2025-05-19 5:33 pm | N/A 2035-05-18 | Nurix Therapeutics Inc. | NRIX | Kunkel Lori Anne Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2025-05-19 Option Award | 2025-05-19 5:33 pm | N/A 2035-05-18 | Nurix Therapeutics Inc. | NRIX | GREGORY JULIA P Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2025-05-19 Option Award | 2025-05-19 5:33 pm | N/A 2035-05-18 | Nurix Therapeutics Inc. | NRIX | Saltzman Edward C Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2025-05-19 Option Award | 2025-05-19 5:33 pm | N/A 2035-05-18 | Nurix Therapeutics Inc. | NRIX | Lacey David L. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2025-05-19 Option Award | 2025-05-19 5:32 pm | N/A 2035-05-18 | Nurix Therapeutics Inc. | NRIX | Kapur Anil Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2025-05-19 Option Award | 2025-05-19 5:32 pm | N/A 2035-05-18 | Nurix Therapeutics Inc. | NRIX | Baynes Roy D. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2025-05-19 Option Award | 2025-05-19 5:32 pm | N/A 2035-05-18 | Nurix Therapeutics Inc. | NRIX | Reinsdorf Judith A Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2025-04-30 Exercise | 2025-04-30 7:35 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 8,956 | $0 | 109,137 (Direct) | View |
| 2025-04-30 Exercise | 2025-04-30 7:35 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 7,674 | $0 | 81,091 (Direct) | View |
| 2025-04-30 Exercise | 2025-04-30 7:35 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 8,636 | $0 | 86,581 (Direct) | View |
| 2025-03-11 Option Award | 2025-03-13 4:09 pm | N/A 2035-03-10 | Nurix Therapeutics Inc. | NRIX | Baynes Roy D. Director | 50,000 | $0 | 50,000 (Direct) | View |
Ownership | 2025-03-13 4:07 pm | N/A 2033-04-10 | Nurix Therapeutics Inc. | NRIX | Baynes Roy D. Director | 0 | $0 | 10,000 (Direct) | View |